Literature DB >> 15009645

HSP27 but not HSP70 has a potent protective effect against alpha-synuclein-induced cell death in mammalian neuronal cells.

Alexandra Zourlidou1, Martin D Payne Smith, David S Latchman.   

Abstract

alpha-Synuclein is a neuronally expressed protein which is mutated in familial Parkinson's disease. We have previously shown that disease-associated mutants of alpha-synuclein cause enhanced neuronal cell death in response to a variety of stimuli, whereas wild-type alpha-synuclein has a protective effect against some stimuli, whilst enhancing the death response to others. We demonstrate, for the first time, that over-expression of the heat shock protein HSP27 has a potent protective anti-apoptotic effect against the damaging effects of wild-type and particularly of mutant alpha-synuclein. In contrast, HSP70 has some protective effect against the damaging effect of the wild-type protein, but has no effect against the mutant proteins, whilst HSP56 has no protective effect in this system. Our results indicate that disease-associated mutants of alpha-synuclein enhance its death-inducing properties and lead to increased apoptosis, which can be mitigated by either the use of specific caspase inhibitors or HSP27 over-expression. This potent protective effect of HSP27 against the mutant and wild-type proteins may be of potential therapeutic importance.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15009645     DOI: 10.1046/j.1471-4159.2003.02273.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  45 in total

Review 1.  Molecular chaperones in Parkinson's disease--present and future.

Authors:  Darius Ebrahimi-Fakhari; Lara Wahlster; Pamela J McLean
Journal:  J Parkinsons Dis       Date:  2011       Impact factor: 5.568

2.  Sequestration of toxic oligomers by HspB1 as a cytoprotective mechanism.

Authors:  Juhi Ojha; Gunasingh Masilamoni; David Dunlap; Ross A Udoff; Anil G Cashikar
Journal:  Mol Cell Biol       Date:  2011-06-13       Impact factor: 4.272

Review 3.  Molecular chaperones and co-chaperones in Parkinson disease.

Authors:  Hemi Dimant; Darius Ebrahimi-Fakhari; Pamela J McLean
Journal:  Neuroscientist       Date:  2012-07-24       Impact factor: 7.519

Review 4.  Opportunities and challenges for molecular chaperone modulation to treat protein-conformational brain diseases.

Authors:  Herman van der Putten; Gregor P Lotz
Journal:  Neurotherapeutics       Date:  2013-07       Impact factor: 7.620

5.  Dominant-positive HSF1 decreases alpha-synuclein level and alpha-synuclein-induced toxicity.

Authors:  Xu Liangliang; Hou Yonghui; E Shunmei; Gong Shoufang; Zhou Wei; Zou Jiangying
Journal:  Mol Biol Rep       Date:  2009-07-17       Impact factor: 2.316

6.  Over-expression of HSP70 attenuates caspase-dependent and caspase-independent pathways and inhibits neuronal apoptosis.

Authors:  Boris Sabirzhanov; Bogdan A Stoica; Marie Hanscom; Chun-Shu Piao; Alan I Faden
Journal:  J Neurochem       Date:  2012-09-28       Impact factor: 5.372

7.  Methamphetamine induces dopamine D1 receptor-dependent endoplasmic reticulum stress-related molecular events in the rat striatum.

Authors:  Subramaniam Jayanthi; Michael T McCoy; Genevieve Beauvais; Bruce Ladenheim; Kristi Gilmore; William Wood; Kevin Becker; Jean Lud Cadet
Journal:  PLoS One       Date:  2009-06-30       Impact factor: 3.240

8.  The HSP70 molecular chaperone is not beneficial in a mouse model of alpha-synucleinopathy.

Authors:  Derya R Shimshek; Matthias Mueller; Christoph Wiessner; Tatjana Schweizer; P Herman van der Putten
Journal:  PLoS One       Date:  2010-04-02       Impact factor: 3.240

9.  Mode of action of S-methyl-N, N-diethylthiocarbamate sulfoxide (DETC-MeSO) as a novel therapy for stroke in a rat model.

Authors:  Payam Mohammad-Gharibani; Jigar Modi; Janet Menzie; Rafaella Genova; Zhiyuan Ma; Rui Tao; Howard Prentice; Jang-Yen Wu
Journal:  Mol Neurobiol       Date:  2014-02-28       Impact factor: 5.590

10.  17-AAG induces cytoplasmic alpha-synuclein aggregate clearance by induction of autophagy.

Authors:  Michael Riedel; Olaf Goldbaum; Lisa Schwarz; Sebastian Schmitt; Christiane Richter-Landsberg
Journal:  PLoS One       Date:  2010-01-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.